Darolutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer [ID6452]

  • In development
  • GID-TA11557
  • Expected publication date: 

Documents

Documents created during the development process.

Invitation to participate

Referral

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6452

Topic selection